Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2022 - 11 - 14 source : Www.biospace.com save search
ImmunoGen Announces FDA Accelerated Approval of ELAHERE™ (mirvetuximab soravtansine-gynx) for the Treatment of Platinum-Resistant Ovarian Cancer
Published: 2022-11-14 (Crawled : 23:00) - biospace.com/
IMGN | News | $31.23 0.03% 49M
|
Health Technology
|
| O: 0.0%
H: 9.24%
C: 7.46%
treatment fda approval cancer ovarian cancer
Lucid Diagnostics Provides Business Update and Third Quarter 2022 Financial Results
Published: 2022-11-14 (Crawled : 23:00) - biospace.com/
LUCD | $0.718 -4.37% -4.57% 270K
|
|
| O: 1.79%
H: 4.14%
C: 0.0%
PAVM | $1.85 -1.6% -1.62% 27K
|
Health Technology
|
| O: 1.87%
H: 0.0%
C: -2.75%
diagnostics financial update results lucid-ms
Rockwell Medical Provides Business Strategy Update and Announces Third Quarter 2022 Financial and Operational Results
Published: 2022-11-14 (Crawled : 21:00) - biospace.com/
RMTI | $1.53 0.99% 0.98% 32K
|
Health Technology
|
| O: 1.94%
H: 19.05%
C: 6.67%
financial update results
Prelude Therapeutics Announces Third Quarter 2022 Financial Results and Provides Business Update
Published: 2022-11-14 (Crawled : 21:00) - biospace.com/
PRLD | $3.9 1.3% 1.28% 25K
|
Health Technology
|
| O: -0.35%
H: 2.3%
C: -8.5%
therapeutics financial update results
CASI PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2022 FINANCIAL RESULTS
Published: 2022-11-14 (Crawled : 21:00) - biospace.com/
CASI | $2.42 -0.41% -0.41% 12K
|
Health Technology
|
| O: 0.51%
H: 3.27%
C: -5.03%
pharmaceuticals financial results
Chemomab Announces Appointment of Matthew Frankel, MD, MBA as Chief Medical Officer
Published: 2022-11-14 (Crawled : 21:00) - biospace.com/
CMMB | $0.66 0.02% 0.02% 7.2K
|
Manufacturing
|
| O: -1.44%
H: 9.74%
C: 0.98%
Biomica CEO to Participate in an Industry Panel Discussion at Microbiome Connect USA 2022 Summit
Published: 2022-11-14 (Crawled : 21:00) - biospace.com/
EVGN | $0.7 -13.64% 63K
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
ceo
Therapeutic Solutions Announces Universal Donor Myeloid Derived Suppressor Therapy Platform for Treatment of Chronic Obstructive Pulmonary Disease (COPD)
Published: 2022-11-14 (Crawled : 19:00) - biospace.com/
TSOI | $0.0007 0.0% 23M
|
Manufacturing
|
| O: 0.0%
H: 1.96%
C: 0.0%
treatment disease solutions universal therapy platform
CV Sciences, Inc. Reports Third Quarter 2022 Financial Results
Published: 2022-11-14 (Crawled : 18:00) - biospace.com/
CVSI | $0.038 -7.56% 130K
|
Manufacturing
|
| O: -3.77%
H: 17.49%
C: 4.44%
financial results
LogicBio Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates
Published: 2022-11-14 (Crawled : 15:00) - biospace.com/
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: -1.95%
H: 1.58%
C: 0.96%
LOGC | $2.07 -0.48%
|
Health Technology
|
| O: 0.49%
H: 0.0%
C: 0.0%
logicbio therapeutics financial results
MyMD Pharmaceuticals Announces Publication of Phase 1 Data for oral TNF-alpha Inhibitor MYMD-1® in Peer-Reviewed Journal Drug Research
Published: 2022-11-14 (Crawled : 15:00) - biospace.com/
MYMD | $2.575 -0.19% -0.19% 23K
|
Manufacturing
|
| O: 0.92%
H: 2.27%
C: -6.82%
pharmaceuticals drug research publication phase 1
ReCode Therapeutics Establishes Scientific Advisory Board
Published: 2022-11-14 (Crawled : 14:20) - biospace.com/
ALLO | $3.365 -1.03% -1.04% 1.6M
|
Health Technology
|
| O: 0.2%
H: 3.09%
C: -3.09%
ADAP | $1.12 10.89% 9.82% 1.1M
|
Health Technology
|
| O: 0.4%
H: 5.16%
C: 0.0%
therapeutics
PerkinElmer Announces its EONIS SCID-SMA Kit is First to Receive Marketing Authorization by U.S. FDA for SMA Screening in Newborns
Published: 2022-11-14 (Crawled : 14:20) - biospace.com/
PKI | $115.24 0.0% 1.6M
|
Health Technology
|
| O: 4.43%
H: 0.0%
C: 0.0%
fda authorization
Charles River Laboratories to Present at November Investor Conferences
Published: 2022-11-14 (Crawled : 14:20) - biospace.com/
CRL | News | $240.13 3.26% 0.0% 610K
|
Commercial Services
|
| O: -1.01%
H: 1.74%
C: -0.33%
VBI Vaccines to Participate in Upcoming Investor Conferences - November 14, 2022
Published: 2022-11-14 (Crawled : 14:20) - biospace.com/
VBIV | $0.591 -1.99% -2.03% 110K
|
Health Technology
|
| O: 0.45%
H: 6.67%
C: 3.33%
vaccine
Scholar Rock Reports Third Quarter 2022 Financial Results and Highlights Business Progress
Published: 2022-11-14 (Crawled : 14:20) - biospace.com/
SRRK 4 | $14.79 5.64% 5.34% 740K
|
Health Technology
|
| O: 0.0%
H: 7.65%
C: 1.06%
financial results
Immunome Reports Third Quarter 2022 Financial Results
Published: 2022-11-14 (Crawled : 14:00) - biospace.com/
IMNM | $14.64 -4.19% -4.37% 890K
|
Health Technology
|
| O: -0.6%
H: 1.21%
C: 1.21%
financial results
Bellerophon Provides Clinical Program Update and Reports Third Quarter 2022 Financial Results
Published: 2022-11-14 (Crawled : 14:00) - biospace.com/
BLPH | $0.0511 -45.37% 15M
|
Health Technology
|
| O: 2.43%
H: 1.57%
C: -0.59%
program financial update results
Vaccinex Reports Third Quarter 2022 Results and Provides Corporate UpdateContinued Progress in Pepinemab Oncology and Neurology Clinical Programs
Published: 2022-11-14 (Crawled : 14:00) - biospace.com/
VCNX | $4.94 -2.76% 7.4K
|
Health Technology
|
| O: -1.68%
H: 4.24%
C: 0.32%
pepinemab results
Agilent Announces AssayMAP Bravo Protein Sample Prep Workbench 4.0
Published: 2022-11-14 (Crawled : 14:00) - biospace.com/
A | $139.2 3.95% -0.14% 2M
|
Health Technology
|
| O: 0.47%
H: 0.47%
C: -1.76%
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.